NCT02730988

Brief Summary

Intentional weight loss in obese, older adults remains controversial. Although caloric restriction, resulting in significant weight and fat mass loss, ameliorates many clinical consequences of obesity, recommendation of intentional weight loss in aging remains controversial. Reluctance stems, at least in part, from loss of lean and bone mass known to accompany overall weight loss and potential exacerbation of age-related risk of disability and fracture. Accordingly, current treatment guidelines call fhttp://google.wfu.edu/or weight-loss therapy that minimizes muscle and bone losses for older persons who are obese and who have functional impairments or medical complications that can benefit from weight loss. Amount of dietary protein consumed during caloric restriction may be a key determinant in maintaining fat-free mass during weight loss. Adequate dietary protein is essential for skeletal muscle anabolism; and, epidemiological evidence in older adults point to a salutary effect of protein intake above the current RDA (0.8 g/kg/day) on body composition. Indeed, a recent position statement by the PRO-TAGE study group advises consumption of 1.0-1.2 g/kg/d in older adults during weight-stable conditions to aid in the maintenance of lean body mass and function. Practical achievement of this level of protein intake is often difficult for obese, older adults undergoing weight loss, yet may be critical to offset weight loss-associated lean mass loss. Preliminary data from our group show a lean mass sparing effect of high protein consumption during caloric restriction. In post-menopausal women undergoing a 5-month intentional weight loss program, consumption of a high (1.2 g/kg/day) versus low (0.6 g/kg/day) protein diet was associated with 50% attenuation (17% vs. 37%) of lean mass loss. While promising, results have yet to be translated to functional changes in a tightly controlled trial of weight loss in obese, older adults. The primary goal of this study is to determine whether adherence to a high protein (≥1.0 g/kg/d) weight loss program results in improved physical function by favorably affecting body composition compared to weight stability in obese, older adults. This will be accomplished by conducting a 24-week trial in 124 obese (BMI 30-40 kg/m2), older (65-79 years) men and women, at risk for mobility disability, randomized to either: (1) high protein intake (≥1.0 g/kg/d; n=62) during weight loss, or (2) weight-stable control (n=62).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 7, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2017

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

January 23, 2019

Completed
Last Updated

January 23, 2019

Status Verified

January 1, 2019

Enrollment Period

1.7 years

First QC Date

February 21, 2016

Results QC Date

July 12, 2018

Last Update Submit

January 16, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in 400 Meter Gait Walk Speed

    Participants were asked to walk 10 laps of a 40-meter course (20 meters out and 20 meters back). The time it took to complete the 400 meters was calculated and reported in meters/second.

    baseline and 24 weeks

Secondary Outcomes (1)

  • Change in 24-week Lean Mass Body Composition

    Baseline and 24-weeks

Study Arms (2)

Weight Loss Lifestyle Counseling

EXPERIMENTAL

The high protein weight loss group follows the Medifast 4 \& 2 \& 1 Plan™, a 1200 calorie, high protein diet targeting \~10% weight loss over 24-weeks through a combination of meal replacement products (MRPs), meal plans, and individual nutrition/behavioral counseling. Participants are guided by the study RD on food purchasing and preparation and encouraged to consume only what is approved from the menu. Participants meet bi-weekly for RD-lead behavioral counseling group classes to provide support and introduce new topics in behavioral weight control. Weight is also measured at each session with progress feedback provided to increase motivation. Participants complete daily food logs to verify compliance to the diet.

Behavioral: Weight Stable Group

Weight Stable Lifestyle Counseling

ACTIVE COMPARATOR

The weight stable control group is monitored bi-weekly by study staff to ensure weight stability over the course of the study. During group sessions, participants are weighed and encouraged to maintain weight within ±5% of baseline. They also receive non-weight loss health related topics presented by study staff. If participants attend 75% of the educational sessions, all baseline and follow-up testing sessions, and maintain weight stability over the course of the study (defined as less than a 5% differential between weight measured at week 0 and 24), they will be eligible to receive up to 3 months of Medifast MRPs along with a 30-60 minute RD-led dietary instruction session on how to follow the Medifast 4 \& 2 \& 1 Plan.

Behavioral: Weight Stable Group

Interventions

The weight stable control group is monitored bi-weekly by study staff to ensure weight stability over the course of the study. During group sessions, participants are weighed and encouraged to maintain weight within ±5% of baseline. They also receive non-weight loss health related topics presented by study staff. If participants attend 75% of the educational sessions, all baseline and follow-up testing sessions, and maintain weight stability over the course of the study (defined as less than a 5% differential between weight measured at week 0 and 24), they will be eligible to receive up to 3 months of Medifast MRPs along with a 30-60 minute RD-led dietary instruction session on how to follow the Medifast 4 \& 2 \& 1 Plan.

Weight Loss Lifestyle CounselingWeight Stable Lifestyle Counseling

Eligibility Criteria

Age65 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 65-79 years
  • BMI=30-40 kg/m2
  • Confirmation of self-reported mobility disability, as assessed by phone screen/clinical staff
  • Self-reported sedentary behavior
  • Non-impaired cognitive function (MoCA\>18)
  • Stability of residence for next 2 years
  • Willing and able to follow dietary protocol
  • Willing to provide informed consent
  • Approved for participation by study physician
  • Not involved in another behavioral or interventional research study
  • Able to provide own transportation to study visits and Intervention
  • Not dependent on a cane or walker
  • No evidence of clinical depression, eating disorder, or other contraindications for participation in voluntary weight loss
  • English literacy

You may not qualify if:

  • Weight loss or gain (±5%) in past 6 months
  • Prior bariatric surgery
  • Multiple food allergies
  • Difficulty with hearing/vision that interferes with study participation
  • Excessive alcohol use (\>14 drinks/week)
  • Smoker (\>1 cigarette/d within year)
  • Insulin-dependent or uncontrolled diabetes (FBG \>140 mg/dl)
  • Uncontrolled hypertension (BP\>160/100 mmHg)
  • Abnormal kidney tests (GFR\<40, creatinine \>2.0)
  • Regular use of medications that may influence body weight or composition
  • Severe systemic disease (diagnosis of Parkinson's disease, chronic liver disease, systemic rheumatic condition, gout, thyroid disease, end stage renal disease) or other systemic diseases/abnormal laboratory values which would preclude participants from safely participating in the protocol or impair their ability to complete the study
  • Severe symptomatic heart disease or cardiovascular procedure within the past 3 months or history/current diagnosis/signs and symptoms of heart failure, with either reduced or preserved Left Ventricular ejection fraction
  • Cancer requiring treatment in past year, except skin cancers
  • Judged unsuitable for the trial for any reason by clinic staff

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University

Winston-Salem, North Carolina, 27106, United States

Location

Related Publications (1)

  • Weaver AA, Houston DK, Shapses SA, Lyles MF, Henderson RM, Beavers DP, Baker AC, Beavers KM. Effect of a hypocaloric, nutritionally complete, higher-protein meal plan on bone density and quality in older adults with obesity: a randomized trial. Am J Clin Nutr. 2019 Feb 1;109(2):478-486. doi: 10.1093/ajcn/nqy237.

MeSH Terms

Conditions

ObesityWeight Loss

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight Changes

Results Point of Contact

Title
Kristen Beavers
Organization
Wake Forest University

Study Officials

  • Kristen M Beavers, PhD

    Wake Forest University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2016

First Posted

April 7, 2016

Study Start

July 1, 2015

Primary Completion

March 30, 2017

Study Completion

April 17, 2017

Last Updated

January 23, 2019

Results First Posted

January 23, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations